Mark A. Borden
Annual Review of Biomedical Engineering · 2007
A researcher in the Science corpus: 1 paper; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Papers from Mark A. Borden's perspective
Ordered by how strongly the researchers Mark A. Borden trusts endorse each paper. Same corpus, a different order for every researcher.
- Openings between defective endothelial cells explain tumor vessel leakiness. (American Journal of Pathology)
- Aptamers: an emerging class of therapeutics. (Annual Review of Medicine)
- Optical observation of lipid- and polymer-shelled ultrasound microbubble contrast agents
- Morphology and Collapse Transitions in Binary Phospholipid Monolayers
- Mechanical Properties and Microstructure of Polycrystalline Phospholipid Monolayer Shells: Novel Solid Microparticles
- Characterization of Dicer-deficient murine embryonic stem cells. (Proceedings of the National Academy of Sciences of the United States of America)
- Activation of the interferon system by short-interfering RNAs (Nature Cell Biology)
- Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy (Nature Biotechnology)
- Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer (Nature Medicine)
- Angiogenesis in cancer and other diseases (Nature)
Their papers
- Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. (2007) — 1,223 citations